ALEC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.29

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

-0.02

EPS Last/This Y

0.51

EPS This/Next Y

0.18

Price

1.77

Target Price

3.1

Analyst Recom

2.86

Performance Q

-27.05

Upside

-2,243.3%

Beta

0.62

Ticker: ALEC

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	ALEC	1.37	0.38	5.07	12403
2026-07-15	ALEC	1.5	0.33	0.00	12018
2026-07-16	ALEC	1.48	0.33	0.00	12017
2026-07-17	ALEC	1.505	0.33	0.00	12017
2026-07-20	ALEC	1.432	0.05	0.00	1753
2026-07-21	ALEC	1.535	0.05	0.00	1759
2026-07-22	ALEC	1.528	0.05	0.00	1830
2026-07-23	ALEC	1.5	0.05	0.00	1885
2026-07-24	ALEC	1.49	0.05	0.00	1925
2026-07-27	ALEC	1.52	0.05	0.00	1927
2026-07-28	ALEC	1.51	0.05	0.00	1929
2026-07-29	ALEC	1.515	0.05	0.00	1929
2026-07-30	ALEC	1.63	0.05	0.62	2019
2026-07-31	ALEC	1.51	0.09	0.00	2199
2026-08-03	ALEC	1.52	0.09	0.00	2257
2026-08-04	ALEC	1.54	0.09	0.00	2334
2026-08-05	ALEC	1.485	0.09	0.00	2389
2026-08-06	ALEC	1.86	0.06	0.06	3437
2026-08-07	ALEC	1.78	0.06	0.50	3747
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	ALEC	1.38	23.9	-	-0.88
2026-07-15	ALEC	1.50	23.9	-	-0.88
2026-07-16	ALEC	1.48	23.9	-	-0.88
2026-07-17	ALEC	1.51	23.9	-	-0.88
2026-07-20	ALEC	1.43	23.9	-	-0.88
2026-07-21	ALEC	1.53	23.9	-	-0.88
2026-07-22	ALEC	1.53	23.9	-	-0.88
2026-07-23	ALEC	1.50	23.9	-	-0.88
2026-07-24	ALEC	1.48	23.9	-	-0.88
2026-07-27	ALEC	1.52	23.9	-	-0.88
2026-07-28	ALEC	1.51	23.9	-	-0.88
2026-07-29	ALEC	1.52	23.9	-	-0.88
2026-07-30	ALEC	1.62	23.9	-	-0.88
2026-07-31	ALEC	1.51	23.9	-	-0.88
2026-08-03	ALEC	1.52	23.9	-	-0.88
2026-08-04	ALEC	1.52	23.9	-	-0.88
2026-08-05	ALEC	1.48	23.9	-	-0.88
2026-08-06	ALEC	1.87	23.9	-	-0.88
2026-08-07	ALEC	1.77	23.9	-	-0.88
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	ALEC	-0.73	1.33	7.35
2026-07-15	ALEC	-0.73	1.33	7.35
2026-07-16	ALEC	-0.73	1.33	7.35
2026-07-17	ALEC	-0.73	1.33	7.35
2026-07-20	ALEC	-0.73	1.18	7.35
2026-07-21	ALEC	-0.73	1.18	7.35
2026-07-22	ALEC	-0.73	1.18	7.35
2026-07-23	ALEC	-0.73	1.18	7.35
2026-07-24	ALEC	-0.73	1.18	7.35
2026-07-27	ALEC	-0.73	1.18	7.29
2026-07-28	ALEC	-0.73	1.18	7.29
2026-07-29	ALEC	-0.73	1.18	7.29
2026-07-30	ALEC	-0.73	1.18	7.29
2026-07-31	ALEC	-0.73	1.18	7.29
2026-08-03	ALEC	-0.73	1.11	7.29
2026-08-04	ALEC	-0.73	1.11	7.29
2026-08-05	ALEC	-0.73	1.11	7.29
2026-08-06	ALEC	-0.73	1.11	7.29
2026-08-07	ALEC	-0.73	1.11	7.29
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.23

Insider Transactions

-0.73

Institutional Transactions

1.11

Beta

0.62

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.9

Max Drawdown 5-Year %

-96.8

Target Price

3.1

P/E

Forward P/E

PEG

P/S

14.26

P/B

19.04

P/Free Cash Flow

EPS

-1.09

Average EPS Est. Cur. Y

-0.88

EPS Next Y. (Est.)

-0.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-850.13

Relative Volume

1.58

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ALEC Healthcare

$1.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

4/25

Volume

3/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

57.9

Range 1M

60.9%

Sup Dist

14.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

17/30

Estimates

2/20

Inst/Vol

7/15

Options

8/10

EPS Yr

38.3%

EPS NY

24.2%

52W%

29.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +74.2% upside

Quality

6/30

Valuation

14/30

Growth

19/25

Stability

8/10

LT Trend

1/5

Upside

+74.2%

Quality

ALEC — P/E HistoricalBiotechnology

Alector, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 103

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.

ALEC

Latest News

—

Caricamento notizie per ALEC…

stock quote shares ALEC – Alector Inc. Stock Price stock today

news today ALEC – Alector Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALEC – Alector Inc. yahoo finance google finance

stock history ALEC – Alector Inc. invest stock market

stock prices ALEC premarket after hours

ticker ALEC fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ALEC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y